Cresco Labs Inc (QX) (CRLBF)

Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank

Access to conventional commercial bank financing enhances financial flexibility and supports Cresco Labs’ disciplined growth and consolidation...

Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a...

Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Cresco Labs Reports First Quarter 2026 Financial Results, Advances Multiple Growth Initiatives

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a...

Cresco Labs Opens Sunnyside Aberdeen, Marking Second Ohio Dispensary Opening in a Month

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the...

Cresco Labs CEO: Rescheduling Ushers in a New Era of Care for Medical Cannabis Patients

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today issued a statement on behalf of Cresco Labs CEO...

Cresco Labs to Report First Quarter 2026 Financial Results on May 8, 2026

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of...

Cresco Labs Opens Sunnyside Bridgeport, Expanding Access in the Ohio Valley

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the...

Cresco Labs Awarded Texas Medical Cannabis License

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a...

Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a...

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of...

Cresco Labs Opens Sunnyside Tamarac, Expanding Patient Access in Broward County, Florida

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the...

Cresco Labs CEO: Rescheduling Marks Historic Shift for Cannabis Industry

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today issued a statement on behalf of Cresco Labs CEO...

Form EFFECT - Notice of Effectiveness